Source:http://linkedlifedata.com/resource/pubmed/id/21135546
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1-3
|
| pubmed:dateCreated |
2011-1-13
|
| pubmed:abstractText |
Left ventricular hypertrophy (LVH) is a major cardiovascular complication in chronic kidney disease (CKD) patients. For a successful management of LVH, the comprehensive understanding of the classical and the new emerging factors associated with LVH is of paramount importance. The aim of the present study was to evaluate the clinical correlates of bone mineral metabolism with the occurrence of LVH in nondialyzed CKD patients.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1421-9735
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
31
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
26-32
|
| pubmed:meshHeading |
pubmed-meshheading:21135546-Adult,
pubmed-meshheading:21135546-Cross-Sectional Studies,
pubmed-meshheading:21135546-Female,
pubmed-meshheading:21135546-Fibroblast Growth Factors,
pubmed-meshheading:21135546-Humans,
pubmed-meshheading:21135546-Hypertrophy, Left Ventricular,
pubmed-meshheading:21135546-Male,
pubmed-meshheading:21135546-Middle Aged,
pubmed-meshheading:21135546-Phosphorus,
pubmed-meshheading:21135546-Prevalence,
pubmed-meshheading:21135546-Renal Insufficiency, Chronic
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy.
|
| pubmed:affiliation |
Nephrology Division, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil. dialisefor@uol.com.br
|
| pubmed:publicationType |
Journal Article
|